Insider Transactions in Q1 2022 at Surgalign Holdings, Inc. (SRGA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
William Scott Durall Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,676
-0.42%
|
$0
$0.3 P/Share
|
|
Mar 15
2022
|
David Lyle Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,200,000
+50.0%
|
-
|
|
Feb 26
2022
|
Enrico Sangiorgio EVP, International |
SELL
Payment of exercise price or tax liability
|
Direct |
7,657
-1.88%
|
$0
$0.31 P/Share
|
|
Feb 15
2022
|
Terry M. Rich President and CEO |
BUY
Open market or private purchase
|
Direct |
434,784
+11.88%
|
$0
$0.46 P/Share
|
|
Feb 15
2022
|
William Scott Durall Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
217,391
+19.83%
|
$0
$0.46 P/Share
|
|
Feb 15
2022
|
Christopher Thunander Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+27.13%
|
$0
$0.46 P/Share
|
|
Jan 26
2022
|
Pawel Lewicki Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,973,750
+41.34%
|
$0
$0.68 P/Share
|